Accredited E-Newsletter Series

Individualized Treatment Approaches in Patients with Newly Diagnosed Hodgkin Lymphoma
Individualized Treatment Approaches in Patients with Newly Diagnosed Hodgkin Lymphoma
CME, CPE
Alison J. Moskowitz, MD
Release Date: September 10, 2018
Expiration Date: September 10, 2019
The management of patients with newly diagnosed Hodgkin lymphoma (HL) continues to evolve as new therapies and treatment approaches are being investigated and introduced. This activity will review helpful, evidence-based strategies for individualizing therapy in the frontline setting by describing emerging treatment regimens for newly diagnosed HL and the latest clinical data regarding these options.

Provided by MediCom Worldwide, Inc.
This activity is supported by educational grants from Bristol-Myers Squibb, Merck & Co., Inc., and Seattle Genetics, Inc.
Begin, Earn CreditView Only, No Credit
 

Managing HL would like to recognize and thank Bristol-Myers Squibb, Merck & Co., Inc., and Seattle Genetics for their educational support of ManagingHodgkinLymphoma.com in 2018.

©2018 MediCom Worldwide, Inc. All rights reserved